Of course. Why wouldn't institutions trade... just much less frequently. I guess one institution unloaded few hundred K or 4-5% of their holding. Not a worry item by itself, but a data point nevertheless.
For me, I am looking for what the institution holding will look like at end of this year, assuming we get our Oct approval and things are on track for main drug and misc items that everyone is speculating about. I surey hope by then, we will have majority of shares in their hand and not retail.
For now, I would like to get through warrant expiration and get "tight lipped" ATRS management to inform us more about PFE drug, TEVA filing and other relevant, material development that will put some real teeth behind the share price and forever say "so long" to sub $4 price level.
Still think we'll touch $5 level within next 30-45 days, and re-test 52 week high. Not sure if we can sustain all of its gain, though, w/o some help from ATRS management and PR w/ teeth.
I may be on the minority, but if we get reasonable run-up between now and Oct, I think there is a chance for a "sell-off" on the news after the approval (for a short while that is). Personal opinion only. It all depends how next 90 days develop, but it's a possibility for me.
Anyhow, that's still 5 months away. For next 60 days, I am very optimistic - technically speaking on the chart, presumeably imminent PRs on some key developments, key conference in June, warrant expiration related share action (if it is like last year, except there is only 1 million warrants expiring this time around).
All good for now, but I am being very careful not to get too complacent IF/When stock moves up w/ rapidity...
